Canadian Research Giant Innovaderm Expands European Presence with Key Executive Hire

2024-11-20 bio

Paris, Wednesday, 20 November 2024.
Innovaderm Research strengthens its European operations by appointing industry veteran Ina Zschocke as Executive VP. With over 20 years of expertise in dermatology and clinical research, Zschocke’s appointment marks a strategic move to enhance the company’s presence across European markets. The Montreal-based firm currently operates in Canada, the U.S., Spain, and Poland, positioning itself for significant European expansion in dermatology and rheumatology research.

Strategic Expansion into European Markets

Innovaderm Research, a prominent clinical research organization (CRO) specializing in dermatology and rheumatology, has made a decisive step towards broadening its European footprint by appointing Ina Zschocke as Executive Vice President of European operations and strategy. This strategic hire underscores Innovaderm’s commitment to enhancing its operational capabilities and market reach across Europe, where it aims to leverage Zschocke’s extensive experience to drive growth and innovation.

A Leader with Proven Expertise

Ina Zschocke brings over two decades of clinical research expertise, particularly in the fields of dermatology, allergology, and aesthetics. Her previous roles include serving as Vice President of Dermatology and Corporate Strategy at TFS HealthScience, where she was instrumental in developing high-quality clinical studies for emerging biopharmaceutical clients. Zschocke’s leadership is expected to play a crucial role in Innovaderm’s mission to fortify its presence in the European market, particularly in dermatology and rheumatology research, which are critical areas of focus for the company.

Innovaderm’s Growing Global Presence

Headquartered in Montreal, Innovaderm Research currently operates in several countries, including Canada, the U.S., Spain, and Poland. The addition of Zschocke to their team is viewed as a pivotal move to enhance client services and operational efficiency on the continent. With a strong foundation already established in these regions, Innovaderm is poised to expand its services and capabilities significantly in Europe, meeting the growing demand for specialized dermatology and rheumatology clinical trials.

Implications for the Healthtech Sector

This development falls under the healthtech sector, as Innovaderm’s work involves conducting clinical trials that contribute to advancements in healthcare, particularly within dermatology and rheumatology. The appointment of Ina Zschocke is expected to bring innovative strategies to the company’s clinical research efforts, potentially accelerating the development of new treatments and therapies. By strengthening its European operations, Innovaderm is well-positioned to contribute significantly to the healthtech landscape, offering enhanced clinical trial capabilities and expertise to a broader client base.

Bronnen

Innovaderm Research European expansion